Brittany M. Kershaw

FDA investigator

Appears on 2 documents from 2025 to 2026, mostly at sites in Pennsylvania. Most often cites general responsibilities of investigators (21 CFR 312.60).

2
Documents on file
1.5
Observations per 483
2025
First seen
2026
Most recent

What they cite most

From 3 observations
  • 21 CFR 312.60
    General responsibilities of investigators
    1
  • 21 CFR 50.27
    Documentation of informed consent
    1
  • 21 CFR 812.100
    General responsibilities of investigators
    1

Activity by year

2025: 1, 2026: 1

Where

Pennsylvania 1

Is Brittany M. Kershaw coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

2 documents, newest first
FirmOpen
483 Dennis J. Hsu, M.DMar 3, 2026 · Pittsburgh, Pennsylvania
483 Jae S. Cho, M.DDec 31, 2025

About this profile

What does Brittany M. Kershaw inspect?

Brittany M. Kershaw appears on 2 documents on file covering 2 sites, mostly in Pennsylvania.

What do they cite most often?

21 CFR 312.60 (general responsibilities of investigators), followed by 21 CFR 50.27 and 21 CFR 812.100.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Brittany M. Kershaw is dated Mar 3, 2026.

FDA Investigator Brittany M. Kershaw: 483s & Inspections · FDA Intel